About Conference
International Conference on Clinical and Experimental Dermatology ICCED-24 is a globally recognized, highly appreciated platform globally with the richness of abundance. To be held on 1st September 2024 at Amravati, this event is sure to repeat its history again. Encapsulating with it the different domains of people, researchers, thought leaders, speakers, and unique visitors.
Highlights
International Conference on Clinical and Experimental Dermatology which is scheduled to be held from 1st September 2024 in Amravati. ICCED-24 will create a global platform to researches, scientists, academicians, policymakers, industry experts to share experiences, discuss research findings and acquire and the desired knowledge in the subject from around the world with many networking opportunities.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Recommended News For You
1.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
2.
A single bout of exercise gives results that could help cancer patients
3.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
4.
Belzutifan Combo Could be Second-Line Option in Advanced RCC
5.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
Conferences That Might Interest You
Recommended Articles For You
1.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
2.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
3.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
4.
Emerging Frameworks in Oncology in Clinical Decision-Making
5.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge